Coagulation factors in spray-dried plasma - a systematic review and meta-analysis
Blood transfusion practices in intensive care - a prospective observational binational study
Outcomes of massive transfusion recipients administered ABO-incompatible fresh frozen plasma
Plasma transfusion in the intensive care unit
Tranexamic acid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (TREATT) - a randomised, double-blind, parallel, phase 3 superiority trial
Resuscitation of adult shocked trauma patients using major haemorrhage protocol guided by viscoelastic haemostatic assays versus formulaic approach
Ultra-massive transfusion - predictors of occurrence and in-hospital mortality from the Australian and New Zealand Massive Transfusion Registry (ANZ-MTR)
Platelet transfusion
Agreement of point-of-care and laboratory lactate levels among trauma patients and association with transfusion
Can clinical guidelines reduce variation in transfusion practice? A pre-post study of blood transfusions during cardiac surgery
A novel method to quantify fibrin–fibrin and fibrin–α2-antiplasmin cross-links in thrombi formed from human trauma patient plasma
Sepsis mortality among patients with haematological malignancy admitted to intensive care 2000–2022 - a binational cohort study
Neutropenic sepsis in the intensive care unit - Differences in clinical profile and outcomes according to the cause of neutropenia
A systematic review of the cost and cost-effectiveness of immunoglobulin treatment in patients with hematological malignancies
Immunoglobulin replacement vs prophylactic antibiotics for hypogammaglobulinemia secondary to hematological malignancy
Economic evaluation - immunoglobulin vs prophylactic antibiotics in hypogammaglobulinemia and hematological malignancies
Rethinking the transfusion pathway in myelodysplastic syndromes - study protocol for a novel randomized feasibility n-of-1 trial of weekly-interval red cell transfusion in myelodysplastic syndromes
Blood lactate after pre-hospital blood transfusion for major trauma by helicopter emergency medical services
Does patient blood management represent good value for money?
Transfusion practices in intensive care units - an Australian and New Zealand point prevalence study
Clinical decision support versus a paper-based protocol for massive transfusion - impact on decision outcomes in a simulation study
Red blood cell transfusion in the intensive care unit
When to use tranexamic acid for the treatment of major bleeding?
Monoclonal antibody levels and protection from COVID-19
Red blood cell transfusion - 2023 AABB international guidelines
Hematologic malignancy - who cares in the end? A retrospective cohort study of markers of quality end-of-life care
Transparent reporting of adaptive clinical trials using concurrently randomised cohorts
Do anemia treatments improve quality of life and physical function in patients with myelodysplastic syndromes (MDS)? A systematic review
Platelet transfusions and predictors of bleeding in patients with myelodysplastic syndromes
Definitions of massive transfusion in adults with critical bleeding - a systematic review
Pre-hospital freeze-dried plasma for critical bleeding after trauma - a pilot randomized controlled trial
Haemovigilance - giving it our best SHOT!
Multicenter, multidisciplinary user-centered design of a clinical decision-support and simulation system for massive transfusion
Current and future strategies to monitor and manage coagulation in ECMO patients
Interventions to reduce infections in patients with hematological malignancies - a systematic review and meta-analysis
Long-term (180-Day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial
Convalescent plasma for people with COVID-19 - a living systematic review
Hyperimmune immunoglobulin for people with COVID-19
Cryopreserved platelets compared with liquid-stored platelets for the treatment of surgical bleeding - protocol for two multicentre randomised controlled blinded non-inferiority trials (the CLIP-II and CLIPNZ-II trials)
Restrictive transfusion thresholds - have we left patient-centered outcomes behind?
Red blood cell alloantibodies in the context of critical bleeding and massive transfusion
ASCOT ADAPT study of COVID-19 therapeutics in hospitalised patients - an international multicentre adaptive platform trial
Early and out-of-hospital use of COVID-19 convalescent plasma - an international assessment of utilization and feasibility
Home delivery - transfusion services when and where they are needed
Whole blood for trauma resuscitation?
Economic evaluation of national patient blood management clinical guidelines in cardiac surgery
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19
Effect of convalescent plasma on organ support-free days in critically ill patients with COVID-19 - a randomized clinical trial
Association between convalescent plasma treatment and mortality in COVID-19 - a collaborative systematic review and meta-analysis of randomized clinical trials
International forum on the management of major haemorrhage - responses
International forum on the management of major haemorrhage - summary
Hemoglobin is a key determinant of quality of life before and during azacitidine-based therapy for myelodysplasia and low blast count acute myeloid leukemia
Age of red blood cells is not associated with in-hospital mortality in massively transfused patients
Fibrinogen in traumatic haemorrhage
International forum on home-based blood transfusion - responses
International forum on home-based blood transfusion - summary
Red cell transfusions - is less always best?
Massive transfusion experience, current practice and decision support - A survey of Australian and New Zealand anaesthetists
How should we use convalescent plasma therapies for the management of COVID-19?
What is clinically significant bleeding?
Epidemiology of massive transfusion - a common intervention in need of a definition
The burden of immune-mediated refractoriness to platelet transfusions in myelodysplastic syndromes
Outpatient transfusions for myelodysplastic syndromes
Managing haematology and oncology patients during the COVID-19 pandemic - interim consensus guidance
Preoperative identification of cardiac surgery patients at risk of receiving a platelet transfusion - The Australian Cardiac Surgery Platelet Transfusion (ACSePT) risk prediction tool
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19 - a living systematic review
How well does your massive transfusion protocol perform? A scoping review of quality indicators